Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study-Reference-Cited by-同舟云学术

Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study

Published:2018-06-19 Issue:3 Volume:48 Page:333-339
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Rowan C. R.¹^ORCID,Keegan D.¹,Byrne K.¹,Cullen G.¹,Mulcahy H. E.¹,Sheridan J.¹,Ryan E. J.¹,de Vries A.²,D'Haens G.³,Doherty G. A.¹

Affiliation:

1. Center for Colorectal Disease; St. Vincent's University Hospital; School of Medicine; University College Dublin; Dublin Ireland

2. Sanquin Diagnostic Services; Amsterdam The Netherlands

3. Department of Gastroenterology; Amsterdam Medical Centre; Amsterdam The Netherlands

Funder

University College Dublin

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14834/fullpdf

Reference41 articles.

1. Crohn disease: epidemiology, diagnosis, and management;Feuerstein;Mayo Clin Proc,2017

2. The Short Health Scale: a valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients;McDermott;J Crohns Colitis,2013

3. Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change;Ordás;Gut,2011

4. The natural history of adult Crohn's disease in population-based cohorts;Peyrin-Biroulet;Am J Gastroenterol,2010

5. Top-down or step-up treatment in Crohn's disease?;Rogler;Dig Dis,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ustekinumab in Hidradenitis Suppurativa: A Systematic Review and Meta-analysis;Dermatology and Therapy;2024-06-22

2. Disseminated Mycobacterial Infection With Reactive Polyarthritis (Poncet’s Disease) During Immune-suppressive Treatment Including Ustekinumab for Pediatric Crohn’s Disease;Pediatric Infectious Disease Journal;2024-02-20

3. Higher Ustekinumab Levels in Maintenance Therapy are Associated with Greater Mucosal Healing and Mucosal Response in Crohn’s Disease: An Experience of 2 IBD Centers;Inflammatory Bowel Diseases;2023-05-09

4. Systematic Review and Meta-analysis: The Association Between Serum Ustekinumab Trough Concentrations and Treatment Response in Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2023-04-18

5. Systematic Review and Meta-Analysis of Observational Studies on the Effectiveness and Safety of Ustekinumab among Patients with Inflammatory Bowel Disease in Eastern and Western Countries;Journal of Clinical Medicine;2023-02-27